BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

766 related articles for article (PubMed ID: 15072623)

  • 1. Metabolic abnormalities associated with renal calculi in patients with horseshoe kidneys.
    Raj GV; Auge BK; Assimos D; Preminger GM
    J Endourol; 2004 Mar; 18(2):157-61. PubMed ID: 15072623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic abnormalities associated with calyceal diverticular stones.
    Auge BK; Maloney ME; Mathias BJ; Pietrow PK; Preminger GM
    BJU Int; 2006 May; 97(5):1053-6. PubMed ID: 16643491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic abnormalities in patients with caliceal diverticular calculi.
    Hsu TH; Streem SB
    J Urol; 1998 Nov; 160(5):1640-2. PubMed ID: 9783922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ability of a limited metabolic assessment to identify pediatric stone formers with metabolic abnormalities.
    Chan KH; Moser EA; Whittam BM; Misseri R; Cain MP; Krambeck A
    J Pediatr Urol; 2018 Aug; 14(4):331.e1-331.e6. PubMed ID: 30177386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multiregional Italian cohort of 24-hour urine metabolic evaluation in renal stone formers.
    Esperto F; Marangella M; Trinchieri A; Petrarulo M; Miano R
    Minerva Urol Nefrol; 2018 Feb; 70(1):87-94. PubMed ID: 28882031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic factors associated with urinary calculi in children.
    Naseri M; Varasteh AR; Alamdaran SA
    Iran J Kidney Dis; 2010 Jan; 4(1):32-8. PubMed ID: 20081302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
    Pak CY; Sakhaee K; Fuller CJ
    Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contributory metabolic factors in the development of nephrolithiasis in patients with medullary sponge kidney.
    Yagisawa T; Kobayashi C; Hayashi T; Yoshida A; Toma H
    Am J Kidney Dis; 2001 Jun; 37(6):1140-3. PubMed ID: 11382681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
    Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
    J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Functional evaluation in patients with kidney calculi].
    Stojimirović B
    Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethnic background has minimal impact on the etiology of nephrolithiasis.
    Maloney ME; Springhart WP; Ekeruo WO; Young MD; Enemchukwu CU; Preminger GM
    J Urol; 2005 Jun; 173(6):2001-4. PubMed ID: 15879804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Urinary lithiasis in transplanted kidney].
    Lancina Martín JA; García Buitrón JM; Díaz Bermúdez J; Alvarez Castelo L; Duarte Novo J; Sánchez Merino JM; Rubial Moldes M; González Martín M
    Arch Esp Urol; 1997 Mar; 50(2):141-50. PubMed ID: 9206940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous management of calculi within horseshoe kidneys.
    Raj GV; Auge BK; Weizer AZ; Denstedt JD; Watterson JD; Beiko DT; Assimos DG; Preminger GM
    J Urol; 2003 Jul; 170(1):48-51. PubMed ID: 12796642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic diagnoses of recurrent stone formers: temporal, geographic and gender differences.
    Huynh LM; Dianatnejad S; Tofani S; Carrillo Ceja R; Liang K; Tapiero S; Jiang P; Youssef RF
    Scand J Urol; 2020 Dec; 54(6):456-462. PubMed ID: 33185135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twenty-four-hour urine chemistries and the risk of kidney stones among women and men.
    Curhan GC; Willett WC; Speizer FE; Stampfer MJ
    Kidney Int; 2001 Jun; 59(6):2290-8. PubMed ID: 11380833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic evaluation of patients with recurrent, multiple or bilateral renal stones in Jaffna.
    Rajendra S
    Ceylon Med J; 2020 Sep; 65(3):56-61. PubMed ID: 34800932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The presence of horseshoe kidney does not affect the outcome of percutaneous nephrolithotomy.
    Miller NL; Matlaga BR; Handa SE; Munch LC; Lingeman JE
    J Endourol; 2008 Jun; 22(6):1219-25. PubMed ID: 18484885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients.
    Ekeruo WO; Tan YH; Young MD; Dahm P; Maloney ME; Mathias BJ; Albala DM; Preminger GM
    J Urol; 2004 Jul; 172(1):159-63. PubMed ID: 15201761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.